Langdahl, Bente http://orcid.org/0000-0002-8712-7199
Hofbauer, Lorenz C.
Ferrari, Serge
Wang, Zhenxun
Fahrleitner-Pammer, Astrid
Gielen, Evelien
Lakatos, Péter
Czerwinski, Edward
Gimeno, Esteban Jódar
Timoshanko, Jen
Oates, Mary
Libanati, Cesar
Funding for this research was provided by:
UCB Pharma
Amgen Inc
Article History
Received: 22 April 2022
Accepted: 23 August 2022
First Online: 29 September 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: All the results presented in this article are in aggregate form, and no personally identifiable information was used for this study.
: BL: received fees and honoraria for lectures and advice from Amgen, Eli Lilly, Gedeon-Richter, Gilead and UCB Pharma; research grants for Aarhus University Hospital from Amgen and Novo Nordisk. LCH: received advisory board honoraria from Alexion, Amgen, Kyowa Kirin International, Shire and UCB Pharma. SF: support from Agnovos, Alexion, Amgen and UCB Pharma; consultant for Agnovos, Alexion, Amgen, Boehringer, Labatec, Myovant, Radius and UCB Pharma. ZW: employee of Amgen and stockholder of Amgen. AFP: research grants (to institution): Amgen, Roche; consultancy/lecture/advisory board fees: Alexion, Amgen, Eli Lilly, Fresenius, Gedeon-Richter, Genericon, Ipsen, Ratiopharm, Roche, Sandoz, Sanofi-Aventis, Shire-Takeda, Stada and UCB Pharma. EG: consultancy fees, lecture fees and/or travel fees from Alexion, Amgen, Sandoz, Takeda and UCB Pharma. PL: grants and/or advisor from Amgen, UCB Pharma, Richter and Teva. EC: grants from Amgen. EJG: consultancy and/or speaker and/or Investigator for Amgen, Asofarma, Astellas, AstraZeneca, Boehringer, BMS, FAES, Helios-Fresenius, Italfarmaco, Janssen, Lilly, MSD, Mundipharma, Novo Nordisk, Sanofi, Shire, Technopharma, UCB Pharma and Viatris. JT: employee of UCB Pharma and stockholder of UCB Pharma. MO: employee of Amgen. CL: employee of UCB Pharma and stockholder of UCB Pharma.